|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.8 TWD | -4.65% |
|
-4.25% | -16.13% |
| Apr. 30 | Apex Biotechnology Corp. Approves Cash Dividend for 2023, Payable on June 14, 2024 | CI |
| Mar. 14 | Apex Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apex Biotechnology Corp. at its Annual General Shareholders' Meeting held on April 30,2024 approved appropriations of earnings in cash dividends to shareholders: TWD 109,945,212 (TWD 1.1 per common share) for 2023, payable on June 14, 2024. Ex-rights (ex-dividend) record date is May 25, 2024.
Ex-rights (ex-dividend) trading date is May 17, 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.13% | 105M | |
| +73.24% | 12.39B | |
| -19.09% | 7.89B | |
| +5.88% | 6.59B | |
| +13.24% | 5.43B | |
| +38.48% | 4.96B | |
| -17.30% | 4.72B | |
| -19.78% | 4.02B | |
| -29.53% | 2.66B | |
| +47.29% | 2.37B |
APEX BIOTECHNOLOGY CORP. 
